Fox Run Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,567	Closed	-$342K	–	871
2025 Q4	$342K	Buy	+12,567	New	+$441K	0.05%	650
2025 Q3	–	Sell	-17,707	Closed	-$589K	–	880
2025 Q2	$589K	Buy	+17,707	New	+$537K	0.1%	397
2025 Q1	–	Sell	-23,839	Closed	-$783K	–	881
2024 Q4	$783K	Buy	+23,839	New	+$1.12M	0.14%	255
2024 Q3	–	Sell	-6,818	Closed	-$294K	–	772
2024 Q2	$294K	Buy	+6,818	New	+$246K	0.06%	560
2019 Q1	–	Sell	-5,542	Closed	-$256K	–	442
2018 Q4	$256K	Buy	+5,542	New	+$342K	0.14%	320
2018 Q3	–	Sell	-8,707	Closed	-$733K	–	549
2018 Q2	$733K	Buy	8,707 +3,833	+79%	+$334K	0.23%	121
2018 Q1	$399K	Buy	+4,874	New	+$377K	0.1%	392
2017 Q4	–	Sell	-8,600	Closed	-$574K	–	646
2017 Q3	$574K	Buy	+8,600	New	+$517K	0.16%	241
2017 Q1	–	Sell	-5,600	Closed	-$234K	–	550
2016 Q4	$234K	Buy	+5,600	New	+$294K	0.12%	380